EL vs SABSW · rev $15.05B vs P/E 0.0
Estee Lauder Companies Inc (EL) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
SABSW does not have a complete income-statement cache yet.
EL currently screens at market cap $31.92B. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the EL and SABSW stock pages for the full models.
Not investment advice.